SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Highbridge Convertible Arbitrage Master Fund, L.P., et al. – ‘4’ for 8/13/07 re: Enzon Pharmaceuticals, Inc.

On:  Wednesday, 8/15/07, at 5:29pm ET   ·   For:  8/13/07   ·   As:  10% Owner   ·   Accession #:  902664-7-2650   ·   File #:  0-12957

Previous ‘4’:  ‘4’ on 8/6/07 for 8/2/07   ·   Next & Latest:  ‘4’ on 8/12/08 for 8/11/08

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/15/07  Highbridge Conv Arbitrage Mas… LP 4          10% Owner   2:18K  Enzon Pharmaceuticals Inc.        Schulte Roth & Z… LLP/FA
          Swieca Henry
          Dubin Glenn
          Highbridge International LLC
          Highbridge Capital Management LLC

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     15K 
                Securities by an Insider -- form4_ex.xml/2.2                     
 2: EX-99       Joint Filer Information                                4      7K 


‘4’   —   Statement of Changes in Beneficial Ownership of Securities by an Insider — form4_ex.xml/2.2




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HIGHBRIDGE CAPITAL MANAGEMENT LLC

(Last)(First)(Middle)
9 WEST 57TH STREET
27TH FLOOR

(Street)
NEW YORKNY10019

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
ENZON PHARMACEUTICALS INC [ ENZN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
8/13/07
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Shares of common stock, $0.01 par ("Common Stock") 8/13/07 P 2,343A$6.462,343I (1) (2)See footnotes (1)(2) (1) (2)
Common Stock 8/13/07 J (3) 2,343D$6.460I (1) (2)See footnotes (1)(2) (1) (2)
Common Stock 8/13/07 P 50,000A$6.4950,000I (2) (4)See footnotes (2)(4) (2) (4)
Common Stock 8/13/07 J (3) 50,000D$6.490I (2) (4)See footnotes (2)(4) (2) (4)
Common Stock 8/13/07 P (3) 50,000A$6.5250,000I (2) (5)See footnotes (2)(5) (2) (5)
Common Stock 8/13/07 J (3) 50,000D$6.520I (2) (5)See footnotes (2)(5) (2) (5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
HIGHBRIDGE CAPITAL MANAGEMENT LLC

(Last)(First)(Middle)
9 WEST 57TH STREET
27TH FLOOR

(Street)
NEW YORKNY10019

(City)(State)(Zip)
1. Name and Address of Reporting Person*
Highbridge International LLC

(Last)(First)(Middle)
P.O. BOX 30554
SEVEN MILE BEACH

(Street)
GEORGE TOWN, GRAND CAYMANE900000

(City)(State)(Zip)
1. Name and Address of Reporting Person*
Dubin Glenn

(Last)(First)(Middle)
C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC
9 WEST 57TH STREET, 27TH FLOOR

(Street)
NEW YORKNY10019

(City)(State)(Zip)
1. Name and Address of Reporting Person*
Swieca Henry

(Last)(First)(Middle)
C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC
9 WEST 57TH STREET, 27TH FLOOR

(Street)
NEW YORKNY10019

(City)(State)(Zip)
1. Name and Address of Reporting Person*
Highbridge Convertible Arbitrage Master Fund, L.P.

(Last)(First)(Middle)
THE CAYMAN CORPORATE CENTRE, 4TH FLOOR
27 HOSPITAL ROAD

(Street)
GEORGE TOWN, GRAND CAYMANE900000

(City)(State)(Zip)
Explanation of Responses:
(1)  489 shares of Common Stock are attributable to Highbridge Convertible Arbitrage Master Fund, L.P. and 1,854 shares of Common Stock are attributable to Highbridge International LLC.
(2)  Highbridge Capital Management, LLC is the trading manager of Highbridge International LLC and Highbridge Convertible Arbitrage Master Fund, L.P. Glenn Dubin is a Co-Chief Executive Officer of Highbridge Capital Management, LLC. Henry Swieca is a Co-Chief Executive Officer of Highbridge Capital Management, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock to the extent such beneficial ownership exceeds such Reporting Person's pecuniary interest.
(3)  Exempt transfer of shares to return shares borrowed in connection with short sales entered into prior to the time that the Reporting Persons became subject to the reporting requirements of Section 16.
(4)  10,427 shares of Common Stock are attributable to Highbridge Convertible Arbitrage Master Fund, L.P. and 39,573 shares of Common Stock are attributable to Highbridge International LLC.
(5)  10,427 shares of Common Stock are attributable to Highbridge Convertible Arbitrage Master Fund, L.P. and 39,573 shares of Common Stock are attributable to Highbridge International LLC.
HIGHBRIDGE CAPITAL MANAGEMENT, LLC /s/ Carolyn Rubin, Managing Director 8/15/07
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Codes:
    J    Other acquisition or disposition.
    P    Open market or private purchase of non-derivative or derivative security.

Top
Filing Submission 0000902664-07-002650   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 9:26:47.2pm ET